C. Faivre-Finn Et Al. , "Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)," LUNG CANCER , vol.151, pp.30-38, 2021
Faivre-Finn, C. Et Al. 2021. Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC). LUNG CANCER , vol.151 , 30-38.
Faivre-Finn, C., Spigel, D. R., Senan, S., Langer, C., Perez, B. A., ÖZGÜROĞLU, M., ... Daniel, D.(2021). Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC). LUNG CANCER , vol.151, 30-38.
Faivre-Finn, Corinne Et Al. "Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)," LUNG CANCER , vol.151, 30-38, 2021
Faivre-Finn, Corinne Et Al. "Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)." LUNG CANCER , vol.151, pp.30-38, 2021
Faivre-Finn, C. Et Al. (2021) . "Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)." LUNG CANCER , vol.151, pp.30-38.
@article{article, author={Corinne Faivre-Finn Et Al. }, title={Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)}, journal={LUNG CANCER}, year=2021, pages={30-38} }